Medx Health Corp.

MDX-X

Analysis and Opinions about MDX-X

Signal
Opinion
Expert
BUY
BUY
February 7, 2020
Brazilian order? He owns warrants and his wife works as a consultant for them. They have orders for 500 units for a melanoma testing product. The delivery is subject to approval by authorities in Brazil. This could lead to hardware sales by June and revenues that begin to show up in Q4. The company thinks there are opportunities in Colombia as well. These markets are 6 times larger than in Canada.
Show full opinionHide full opinion
Medx Health Corp. (MDX-X)
February 7, 2020
Brazilian order? He owns warrants and his wife works as a consultant for them. They have orders for 500 units for a melanoma testing product. The delivery is subject to approval by authorities in Brazil. This could lead to hardware sales by June and revenues that begin to show up in Q4. The company thinks there are opportunities in Colombia as well. These markets are 6 times larger than in Canada.
BUY
BUY
October 21, 2019
They have low level light therapy. They were recognized about two months ago for mucusitis treatment and its prevention. They also make equipment to detect melanoma.
Show full opinionHide full opinion
Medx Health Corp. (MDX-X)
October 21, 2019
They have low level light therapy. They were recognized about two months ago for mucusitis treatment and its prevention. They also make equipment to detect melanoma.
BUY
BUY
October 11, 2018

They have a new President and CEO. They released a new web site. They replace needles for dental work with laser. On the innovative side, their Durham product gives totally secure examination of a mole with results in 72 hours. The long awaited approval of the devices in Mexico is expected soon. There are expected global partnerships. He thinks there are really good opportunities for them.

Show full opinionHide full opinion
Medx Health Corp. (MDX-X)
October 11, 2018

They have a new President and CEO. They released a new web site. They replace needles for dental work with laser. On the innovative side, their Durham product gives totally secure examination of a mole with results in 72 hours. The long awaited approval of the devices in Mexico is expected soon. There are expected global partnerships. He thinks there are really good opportunities for them.

BUY
BUY
July 24, 2018

He thinks there is good opportunity for this medical device manufacturer with the arrival of a new CEO. Note: His wife works as a consultant for this company.

Show full opinionHide full opinion

He thinks there is good opportunity for this medical device manufacturer with the arrival of a new CEO. Note: His wife works as a consultant for this company.

BUY
BUY
February 20, 2018

This company sells technology that looks with light 2 mm below the skin to determine whether you have melanoma, moles or otherwise. Skin cancer is a growing problem and this is a good product for it. The company is gaining customers in Spanish-speaking countries (Spain, Mexico, etc.)

Show full opinionHide full opinion
Medx Health Corp. (MDX-X)
February 20, 2018

This company sells technology that looks with light 2 mm below the skin to determine whether you have melanoma, moles or otherwise. Skin cancer is a growing problem and this is a good product for it. The company is gaining customers in Spanish-speaking countries (Spain, Mexico, etc.)

COMMENT
COMMENT
January 5, 2018

This company's product is truly revolutionary, because it looks millimetres below the skin’s surface to actually see what is going on. They take a picture, send it on a secure basis to a dermatologist, who then sees the situation. A year ago, they retooled their laser therapy device, and that is selling quite well. They are working on some improved software to make it easier on a "plug-and-play" basis for the actual melanoma detection device. A great product. The company needs sales of about $1.8 million to break even, and they have $9 million of tax loss carry forward. His expectation is that by Q3 of 2018, they will be profitable. He owns warrants on this.

Show full opinionHide full opinion

This company's product is truly revolutionary, because it looks millimetres below the skin’s surface to actually see what is going on. They take a picture, send it on a secure basis to a dermatologist, who then sees the situation. A year ago, they retooled their laser therapy device, and that is selling quite well. They are working on some improved software to make it easier on a "plug-and-play" basis for the actual melanoma detection device. A great product. The company needs sales of about $1.8 million to break even, and they have $9 million of tax loss carry forward. His expectation is that by Q3 of 2018, they will be profitable. He owns warrants on this.

BUY
BUY
August 25, 2017

Their numbers were up 13%. They have a device that looks at moles for Melanoma. They are now focusing on health and safety for workers. There is a pilot going on with Loblaw’s.

Show full opinionHide full opinion

Their numbers were up 13%. They have a device that looks at moles for Melanoma. They are now focusing on health and safety for workers. There is a pilot going on with Loblaw’s.

Showing 1 to 7 of 7 entries
  • «
  • 1
  • »